In August 2012, a class action was brought on behalf of New Yorkers claiming, among other things, that the makers of pill, TA-65, which is marketed as an anti-aging supplement, “have failed to reasonably warn consumers of the potential dangerous consequences associated with TA-65 telomerase activation and malignant tumor formation.”  (Egan, et al. v. Telomerase Activation Sciences, Inc. et al., Case No. 652533/2012, S.C.N.Y.)

 


The Latest

Filters

LegXercise Pro

Ad Alert

LegXercise Pro

Device maker does not have the clinical proof to back up its clinically proven claims.

Crypto.com

Ad Alert

Crypto.com

Ad regulator bans Facebook ad for failing to disclose risks of investing in NFTs.


Show More